Peer-reviewed journal articles (260)
  1. 35. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Claessens, F., De Ridder, D., Decaestecker, C., & Joniau, S. (2018). Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores. Scientific reports, 8(1), 14326. doi:10.1038/s41598-018-32711-9
  2. 36. Tosco, L., Laenen, A., Gevaert, T., Salmon, I., Decaestecker, C., Davicioni, E., Buerki, C., Claessens, F., Swinnen, J., Goffin, K., Oyen, R., Everaerts, W., Moris, L., De Meerleer, G., Haustermans, K., Joniau, S., & P.E.A.R.L. (ProstatE cAncer Research Leuven), (2018). Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC cancer, 18(1), 354. doi:10.1186/s12885-018-4275-z
  3. 37. Roumeguere, T., Legrand, F., El Rassy, E., Idrissi Kaitouni, M., Albisinni, S., Rousseau, A., Vanhaeverbeek, M., Rorive, S., Decaestecker, C., Debeir, O., Zouaoui Boudjeltia, K., & Aoun, F. (2018). A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer. Future science OA, 4(2), FSO266. doi:10.4155/fsoa-2017-0084
  4. 38. Fontaine, M., Vogel, I., Van Eycke, Y.-R., Galuppo, A., Ajouaou, Y., Decaestecker, C., Kassiotis, G., Moser, M., & Leo, O. (2018). Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells. EMBO journal, 37(3), 398-412. doi:10.15252/embj.201796881
  5. 39. Buisseret, L., Desmedt, C., Garaud, S., Fornili, M., Wang, X., Van den Eyden, G., de Wind, A., Duquenne, S., Boisson, A., Naveaux, C., Rothé, F., Rorive, S., Decaestecker, C., Larsimont, D., Piccart-Gebhart, M., Biganzoli, E., Sotiriou, C., & Willard-Gallo, K. (2017). Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer. Modern pathology, 30(9), 1204-1212. doi:10.1038/modpathol.2017.43
  6. 40. Arcolia, V., Boutry, S., Laurent, S., Saussez, S., Journé, F., Wattier, A., Leteurtre, E., Renaud, F., Gabius, H.-J., Remmelink, M., Decaestecker, C., & Rodriguez, A. (2017). Galectin-1 is a diagnostic marker involved in thyroid cancer progression. International journal of oncology, 51(3), 760-770. doi:10.3892/ijo.2017.4065
  7. 41. Verset, L., Tommelein, J., Decaestecker, C., De Vlieghere, E., Bracke, M., Salmon, I., De Wever, O., & Demetter, P. (2017). ADAM-17/FHL2 Colocalisation Suggests Interaction and Role of These Proteins in Colorectal Cancer. Tumor biology, 39(3), 1010428317695024. doi:10.1177/1010428317695024
  8. 42. Van Eycke, Y.-R., Allard, J., Salmon, I., Debeir, O., & Decaestecker, C. (2017). Image processing in digital pathology: an opportunity to solve inter-batch variability of immunohistochemical staining. Scientific Reports, 7, 42964. doi:10.1038/srep42964
  9. 43. Le Bon, S., Lechien, J., Ennaji, M., Decaestecker, C., Horoi, M., & Saussez, S. (2017). Radiofrequence des cornets inferieurs versus turbinectomie partielle : Une evaluation des symptomes post-operatoires. Revue de laryngologie, d'otologie et de rhinologie, 138(1), 21-25.
  10. 44. Descamps, G., Karaca, Y., Lechien, J., Kindt, N., Decaestecker, C., Remmelink, M., Larsimont, D., Andry, G., Hassid, S., Rodriguez, A., Khalifé, M., Journé, F., & Saussez, S. (2016). Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Journal of cancer research and clinical oncology, 142(10), 2185-2196. doi:10.1007/s00432-016-2203-7
  11. 45. Verset, L., Tommelein, J., Moles Lopez, X., Decaestecker, C., Boterberg, T., De Vlieghere, E., Salmon, I., Mareel, M., Bracke, M. E., De Wever, O., & Demetter, P. (2015). Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer. Radiotherapy and oncology, 116(3), 449-54. doi:10.1016/j.radonc.2015.05.007
  12. 46. Maris, C., D'Haene, N., Trepant, A.-L., Le Mercier, M., Sauvage, S., Allard, J., Rorive, S., Demetter, P., Decaestecker, C., & Salmon, I. (2015). IGF-IR: a new prognostic biomarker for human glioblastoma. British Journal of Cancer, 113(5), 729-737. doi:10.1038/bjc.2015.242
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next >>